IMCR
Immunocore Holdings Ltd
30.50$
+0.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 3.1% | 0.3% | 0.3% | 2.3% | 0.6% | 0.4% | 0.9% | 1.1% | 0.5% | 3.4% | 0.4% | 0.9% | 1.2% | |
| 96.9% | 99.7% | 99.7% | 97.7% | 99.4% | 99.6% | 99.1% | 98.9% | 99.5% | 96.6% | 99.6% | 99.1% | 98.8% | |
| 61.5% | 64.9% | 81.5% | 67.7% | 65.8% | 72.4% | 60.1% | 70.4% | 68.1% | 75.4% | 57.3% | 63.8% | 65.4% | |
| 43.6% | 83.9% | 55.7% | 33.9% | 29.8% | 58.9% | 42.8% | 43.7% | 38.4% | 55.1% | 35.5% | 37.9% | 40.7% | |
| 116.3% | 124.0% | 137.2% | 119.0% | 110.0% | 122.8% | 103.0% | 114.1% | 106.4% | 115.5% | 92.8% | 101.6% | 103.2% | |
| -19.4% | -24.3% | -37.6% | -21.2% | -10.6% | -23.1% | -3.9% | -15.2% | -6.9% | -18.8% | 6.8% | -2.6% | -4.3% | |
| 2.0% | 1.8% | 4.6% | 5.0% | 4.7% | 8.3% | 3.2% | 3.1% | 2.9% | 3.9% | 2.2% | 2.6% | 2.8% | |
| 3.4% | -36.5% | -34.2% | -13.4% | 7.6% | -29.5% | 6.5% | -9.9% | 0.3% | -15.1% | 12.4% | -0.4% | 0.3% | |
| -0.3% | -8.4% | 0.5% | 2.0% | -3.3% | -1.2% | 1.1% | 0.6% | -0.5% | 13.7% | 0.3% | 0.3% | 2.6% | |
| 3.7% | -28.1% | -34.7% | -15.4% | 10.9% | -28.3% | 5.4% | -10.5% | 0.8% | -28.8% | 12.2% | -0.7% | -2.3% | |
| 8.1% | -34.7% | -28.1% | -7.1% | 13.6% | -18.2% | 10.6% | -6.5% | 4.0% | -10.4% | 15.5% | 3.1% | 4.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.